Brinzolamide and Brinzolamide Tartrate Ophthalmic Suspension is a fixed-dose combination ophthalmic preparation indicated for the treatment of patients with open-angle glaucoma or ocular hypertension who require multiple medications to achieve target IOP. Brinzolamide lowers intraocular pressure, thereby reducing aqueous humor secretion. Brimonidine Tartrate works by both reducing aqueous humor production and increasing uveoscleral outflow. Together, they provide a complementary and additive effect, ensuring sustained IOP reduction, reducing the risk of optic nerve damage and vision deterioration.
Explore our diverse range of pharmaceutical manufacturing categories, designed to deliver high-quality, reliable, and innovative healthcare solutions across multiple dosage forms.
Corporate Office
Plot No. :46 First Floor, Industrial Area Phase-2, Chandigarh-160002, India.
Manufacturing Unit
Village Kondi, Post Thana, District Solan, Baddi 173205 Himachal Pradesh, India.
